Your safety is our priority. We’re doing more than ever to help ensure your protection and well-being when you come see us for care. Learn more.

A Message to Our Community: Changes to our visitation policy are in effect until further notice.

Recent News

Irvine school nurses, staff learn Stop the Bleed techniques to respond in mass-casualty situation

Irvine school nurses and athletic trainers on Tuesday, Jan. 30, learned simple techniques that could save lives in a shooting or other ...

Read More

Families anticipate exciting community blessing of surgical center

A community is as strong as its hospital, and with recent investments into Covenant Health Plainview, it’s evident that to our friends ...

Read More

Severe Flu Season Tightens Its Grip on U.S.

Americans are being hit with one of the worst flu seasons in years, with misery now widespread across 46 states, health officials say. In ...

Read More

About St. Joseph Health

SJH provides a full range of care facilities including 16 acute care hospitals, home health agencies, hospice care, outpatient services, skilled nursing facilities, community clinics and physician groups. All of our hospital and home health entities are accredited by the Joint Commission. In our award-winning facilities, SJH maintains a "continuum of care," matched to the diverse needs of the urban centers, smaller cities and rural communities who depend on us every day.

Tiffany Y. Wu, MD

  • Vascular Surgery
Additional Language Spoken
Hokkien, Spanish, Chinese - Mandarin, English
Medical Groups & Affiliations
  • St. Joseph Heritage Medical Group
  • St. Joseph Hospital Affiliated Physicians
Vascular & Interventional Specialists Of Orange County
1140 West La Veta Avenue
Suite 850
Orange, CA 92868
Accepting New Patients

Primary Office

Vascular & Interventional Specialists Of Orange County
1140 West La Veta Avenue
Suite 850
Orange, CA 92868
Get Directions
(714) 560-4450
(714) 560-4455
Mon - Fri: 9 a.m. - 5 p.m.

More Information

  • Meet The Doctor

    Specialties & Education

    Primary Specialties
    • Vascular Surgery
    Education & Training
    • Medical School
      Keck School of Medicine of USC - 2010
    • Residency
      Huntington Memorial Hospital - 2015
    • Fellowship
      Stanford University Hospital - 2017
    Areas of Interest
    Endovascular Surgery, Peripheral Vascular Disease, Aneurysms, Vascular Surgery, Dialysis Access Surgery & Maintenance, Venous Insufficiency
  • Biography



    Dr. Wu is a Southern California native who completed her vascular surgery training at Stanford Hospital and general surgery training at Huntington Memorial Hospital. She attended Keck School of Medicine at the University of Southern California for her medical training as well as Harvard University for her undergraduate studies.


    1. Wu T, Lee JT. Evolution of Endovascular Management of Common Iliac Artery Aneurysms. Endovascular Today. 2016 Mar; 15(3): S3-7.
    2. Wu T, Ham SW, Katz SO. Predictors and Consequences of Hemodynamic Instability Following Carotid artery Stenting. Annals of Vascular Surgery. 2015 Aug; 29(6): 1281-5.
    3. Wu T, Weaver F, Katz SG. Identification of a High-Risk Subset of Patients Undergoing Infrainguinal Bypass Surgery. AMA Surg.2015 Jan; 150(1 ):82-4. Publication Status: Published.
    4. Wu T, Akopian G, Katz S. Patients at Elevated Risk of Major Adverse Events Following Endarterectomy for Asymptomatic Carotid Stenosis. American Journal of Surgery. 2015 Jun; 209(6 ): I 069-73. Publication Status: Published.
    5. Wu T, Giesler G, Herscu G, Ochoa C, Reed R, Rowe V, Yaghmai B, Katz S. Agreement among observers in the assignment ofTransAtlantic Inter-Society Consensus classification and runoff score. Journal of Vascular Surgery. 2013 Nov; 58(5): 1254-1258. Publication Status: Published.
    6. Woodley D, Wang X, Zhou H, Wu T, Muirhead T, Chen M. Bone marrow stem cells improve the survivability of RDEB mice but do not correct the fundamental type VII collagen defect. Journal of Investigative Dermatology. 2008 Apr; 128(NA): S 126-S 126. Publication Status: Published.
    7. Schniiriger B, Inaba K, Wu T, Eberle BM, Belzberg H, Demetriades D. Crystalloids After Primary Colon Resection and Anastomosis at Initial Trauma Laparotomy: Excessive Volumes Are Associated With Anastomotic Leakage. Journal ofTrauma. 2011 Mar; 70(3): 603-610. Publication Status: Published.
    8. Schnuriger B, Inaba K, Eberle BM, Wu T, Talving P, Bukur M, Belzberg H, Demetriades D. Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. Journal of Gastrointestinal Surgery. 2010 Aug; 14(8): 1304-1310. Publication Status: Published.
    9. Ray E, Wu T, Nazarian Mobin SS, Reinisch J, Urata MM. Review of options for burned ear reconstruction. Journal ofCraniofacial Surgery. 2010 Jul; 21(4): I 165-1169. Publication Status: Published.
    10. Price S, Edwards S, Wu T, Minehan T. Synthesis ofC-Aryl-2,3-glycopyranosides via Uncatalyzed Addition ofTriarylindium Reagents to Glycals. Tetrahedron Letters. 2004 Jun; 45(27): 5 I 97-5324. Publication Status: Published.
    11. Mouzakis K, Wu T, Haushalter K. Biochemical properties of common variants of human 8-oxoguanine DNA glycosylase. The FASEB Journal. 2006 Mar; 20(NA): A 1361. Publication Status: Published.


    Oral Presentations

    1. Operative Results of Iliac Artery Endo fibrosis in High-performance Athletes. Oral Presentation accepted at 2016 Western Vascular Society Annual Meeting; Colorado Springs, CO.
    2. Predictors and Consequences ofHemodynamic Instability Following Carotid Artery Stenting. Oral Presentation presented at: 2014 Western Vascular Society Annual Meeting; Coronado Bay, CA.
    3. Surgical Site Infection Following lnfrainguinal Bypass Procedures. Oral Presentation presented at: 2014 Society for Clinical Vascular Surgery Annual Meeting; Carlsbad, CA.
    4. Identification ofa high risk subset of patients undergoing infrainguinal bypass surgery. Oral Presentation presented at: 2014 Pacific Coast Surgical Association Annual Meeting; Dana Point, CA.
    5. Identification of High Risk Population Undergoing Endarterectomy for Asymptomatic Carotid Stenosis. Oral Presentation presented at: 2013 Western Surgical Association Annual Meeting; Salt Lake City, UT.
    6. The Assignment ofTASC Classification and Runoff Score: Are we speaking the same language?. Oral Presentation presented at: 2012 Western Surgical Association Annual Meeting; Colorado Springs, CO.
    7. Bone marrow stem cells improve the survivability of RDEB mice but do not correct the fundamental type VII collagen defect. Oral Presentation presented at: 2008 International Investigative Dermatology Meeting; Kyoto, Japan.

    Poster Presentation

    1. Practice patterns for gallstone pancreatitis: a 5 year experience at a community-based teaching hospital. Poster presented at: 2012 Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting; San Diego, CA.